Speaker illustration

Doctor Donato Cappetta

Second University of Naples, Naples (Italy)

Dapagliflozin improves diastolic performance in an animal model of heart failure with preserved ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Ion Channels, Electrophysiology

Session: Basic Science - HFpEF and Pulmonary Hypertension

Thumbnail

Dipeptidyl peptidase 4 inhibitor sitagliptin ameliorates renal function in a model of hypertension-induced cardiorenal disease

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Cardiac Diseases

Session: Basic Science - Cardiac Diseases

Thumbnail

Dipeptidyl peptidase 4 inhibitor sitagliptin ameliorates cardio-renal axis in Dahl salt-sensitive hypertensive rat model

Event: Frontiers in CardioVascular Biology 2018

Topic: Heart Failure

Session: LBS Poster Session 2

Thumbnail

Effects of SGLT2 inhibitor dapagliflozin in a non-diabetic hypertensive model of heart failure with preserved ejection fraction

Event: Frontiers in CardioVascular Biology 2018

Topic: Heart Failure

Session: LBS Poster Session 2

Thumbnail

Resveratrol attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of doxorubicin cardiomyopathy

Event: HEART FAILURE 2016

Topic: Cardiomyopathies

Session: Basic Science: Cardiomyopathy

Thumbnail

This platform is supported by

logo Novo Nordisk